Our Product: Clinical Performance and value (CPV) vignettes

Our team of doctors and data scientists develops our CPVs in conjunction with clients’ leadership to strategically target areas of clinical focus. All cases undergo extensive rounds of edits with client leadership to ensure the utmost accuracy and alignment with mission and practice.

Our experience helping 20,000+ physicians has provided us expertise in:

  • All medical specialties

  • The most common to the rarest of conditions

  • All provider types: Doctors, nurse practitioners, physician assistants, pharmacists, etc

  • All locations: Quaternary U.S. hospital systems to rural U.S. primary care clinics to entire national health systems in developing-world settings

As these are virtual patients, our clients have complete control over their presentation and disease course. Life science clients, for example, can specify not only their patients’ disease states, but also their comorbidities, demographic variables, disease severity, and any other key variables in proving the value of their product. These factors result in a randomized clinical trial that is multiple-fold quicker and cheaper to produce, especially for rare conditions, and has a track record of acceptance by governmental and private payers. 

 Similarly, health system leadership can specify the disease states, severities and progressions of greatest importance to help them achieve their clinical and financial goals by lowering cost, reducing clinical variation and improving clinical quality.

Our Platform

Providers care for their simulated patients on our proprietary platform, specifically designed to:

  • accurately mimic real-life patient encounters

  • provide a pleasing user interface that delights and retains providers

  • allow for meaningful data collection

Our Process


At each step, (s)he will be asked to make the same medical decisions she makes in her daily practice, such as:

  1. Conducting a focused history and selecting high-value parts of the physical exam

  2. Ordering relevant tests

  3. Making accurate diagnoses

  4. Prescribing effective treatments

  5. Implementing evidence-based medicine across transitions of care




After completing their CPVs, providers receive feedback on their care decisions, highlighting:

  • Accuracy, broken down by stage of care or disease state

  • Variation from evidence-based standards and local practice patterns

  • Cost of unnecessary care provided

Providers can compare themselves on all these metrics to their peers. Upon request, QURE can also lead facilitated discussions after CPV administration, highlighting growth to-date, reinforcing the clinical areas with the greatest potential for quality and cost improvement, and ironing out the areas of greatest clinical difference.

Most providers will complete multiple rounds CPVs.

 For our life science clients, this may take the form of a randomized controlled trial:

 Round 2:

Demonstrates difference in diagnosis and/or treatment for intervention arm(s) given access to new life-science product.

Round 1:

Demonstrates the existing variability and practice gaps in diagnosis and treatment of a condition of interest.

For our global health and health system/payer clients, these multiple rounds allow for regular feedback and rigorous evaluation of improvement round-over-round. In keeping with educational science, we have found that repeated, spaced exposure to clinical cases and feedback leads to the most longstanding gains in clinical quality.